Piper Sandler Reiterates "Overweight" Rating for Integer (NYSE:ITGR)

Piper Sandler reissued their overweight rating on shares of Integer (NYSE:ITGR - Free Report) in a research note released on Friday, Benzinga reports. The brokerage currently has a $140.00 price objective on the medical equipment provider's stock, up from their prior price objective of $125.00.

Other equities analysts have also recently issued reports about the stock. KeyCorp lifted their price target on shares of Integer from $139.00 to $144.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 15th. Benchmark lifted their price target on shares of Integer from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Monday. Citigroup lifted their price target on shares of Integer from $124.00 to $130.00 and gave the stock a "neutral" rating in a research report on Tuesday, October 1st. Oppenheimer began coverage on shares of Integer in a research report on Tuesday, July 16th. They set an "outperform" rating and a $135.00 price target on the stock. Finally, Bank of America lifted their price target on shares of Integer from $135.00 to $145.00 and gave the stock a "buy" rating in a research report on Tuesday, October 1st. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $139.75.

Integer Trading Down 0.8 %

NYSE ITGR traded down $0.99 during trading hours on Friday, hitting $125.77. The company's stock had a trading volume of 187,373 shares, compared to its average volume of 312,382. The stock has a fifty day moving average of $127.37 and a 200 day moving average of $120.86. Integer has a twelve month low of $73.40 and a twelve month high of $133.53. The firm has a market capitalization of $4.21 billion, a P/E ratio of 44.61, a PEG ratio of 1.86 and a beta of 1.08. The company has a quick ratio of 1.96, a current ratio of 3.29 and a debt-to-equity ratio of 0.73.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.07. Integer had a net margin of 6.31% and a return on equity of 11.48%. The business had revenue of $431.42 million for the quarter, compared to analyst estimates of $440.59 million. During the same period in the prior year, the business posted $1.27 earnings per share. Integer's revenue was up 8.7% compared to the same quarter last year. Equities research analysts forecast that Integer will post 5.3 earnings per share for the current fiscal year.

Insider Buying and Selling at Integer

In other news, Director Jean M. Hobby sold 11,960 shares of the company's stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the completion of the sale, the director now owns 2,280 shares of the company's stock, valued at approximately $272,824.80. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 2.00% of the company's stock.

Institutional Trading of Integer

A number of institutional investors and hedge funds have recently made changes to their positions in ITGR. Guidance Capital Inc. bought a new stake in shares of Integer during the 1st quarter worth approximately $500,000. Congress Wealth Management LLC DE lifted its stake in Integer by 7.6% in the 1st quarter. Congress Wealth Management LLC DE now owns 69,328 shares of the medical equipment provider's stock valued at $8,089,000 after purchasing an additional 4,873 shares during the last quarter. AlphaMark Advisors LLC bought a new position in Integer in the 1st quarter valued at approximately $359,000. Tributary Capital Management LLC lifted its stake in Integer by 1.2% in the 1st quarter. Tributary Capital Management LLC now owns 285,677 shares of the medical equipment provider's stock valued at $33,333,000 after purchasing an additional 3,513 shares during the last quarter. Finally, Azzad Asset Management Inc. ADV lifted its stake in Integer by 7.9% in the 1st quarter. Azzad Asset Management Inc. ADV now owns 7,772 shares of the medical equipment provider's stock valued at $907,000 after purchasing an additional 566 shares during the last quarter. Institutional investors own 99.29% of the company's stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.